Trade Zoetis - ZTS CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.25 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02354% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001318% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 162.61 |
| Open | 162.86 |
| 1-Year Change | -3.83% |
| Day's Range | 161.45 - 163.54 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Mar 28, 2025 | 162.61 | -0.97 | -0.59% | 163.58 | 165.16 | 162.61 |
| Mar 27, 2025 | 164.52 | 1.75 | 1.08% | 162.77 | 165.32 | 161.95 |
| Mar 26, 2025 | 162.59 | 1.64 | 1.02% | 160.95 | 163.06 | 160.48 |
| Mar 25, 2025 | 161.00 | -1.19 | -0.73% | 162.19 | 164.06 | 160.16 |
| Mar 24, 2025 | 162.97 | 2.08 | 1.29% | 160.89 | 164.90 | 160.89 |
| Mar 21, 2025 | 162.56 | 1.11 | 0.69% | 161.45 | 162.88 | 160.12 |
| Mar 20, 2025 | 162.85 | 0.43 | 0.26% | 162.42 | 163.94 | 161.90 |
| Mar 19, 2025 | 163.33 | 0.68 | 0.42% | 162.65 | 164.75 | 162.34 |
| Mar 18, 2025 | 163.88 | -0.22 | -0.13% | 164.10 | 165.21 | 163.08 |
| Mar 17, 2025 | 164.70 | 4.37 | 2.73% | 160.33 | 165.74 | 160.33 |
| Mar 14, 2025 | 161.07 | 2.12 | 1.33% | 158.95 | 161.36 | 158.00 |
| Mar 13, 2025 | 159.52 | -0.71 | -0.44% | 160.23 | 161.44 | 159.43 |
| Mar 12, 2025 | 161.31 | -1.54 | -0.95% | 162.85 | 163.57 | 160.41 |
| Mar 11, 2025 | 164.02 | -5.69 | -3.35% | 169.71 | 171.45 | 163.87 |
| Mar 10, 2025 | 171.72 | 3.71 | 2.21% | 168.01 | 176.84 | 168.01 |
| Mar 7, 2025 | 169.93 | 4.73 | 2.86% | 165.20 | 170.82 | 164.91 |
| Mar 6, 2025 | 167.04 | 1.83 | 1.11% | 165.21 | 167.42 | 164.32 |
| Mar 5, 2025 | 166.61 | -0.84 | -0.50% | 167.45 | 171.56 | 165.15 |
| Mar 4, 2025 | 169.99 | 0.42 | 0.25% | 169.57 | 174.60 | 169.57 |
| Mar 3, 2025 | 170.31 | 4.22 | 2.54% | 166.09 | 170.49 | 165.91 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Zoetis Company profile
About Zoetis Inc
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company operate its business through two segments: the United States and International. Within each of these operating segments, it offers a product portfolio for both companion animal and livestock customers. The Company market its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America, and its products are sold in more than 100 countries.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Zoetis Inc revenues increased 16% to $7.78B. Net income increased 24% to $2.04B. Revenues reflect International segment increase of 20% to $3.65B, US segment increase of 14% to $4.04B, United States segment increase of 14% to $4.04B, Other emerging markets segment increase of 19% to $778M. Net income benefited from Interest Expense -Gross decrease of 2% to $244M (expense).
Equity composition
Class A Common Stock $.01 Par, 2/13, 5M auth., 86,100,000 issd. Insiders own less than 1%. Class B Common Stock $.01 Par, 1B auth., 413,900,000 issd.
| Industry: | Veterinary Drugs |
10 Sylvan Way
PARSIPPANY
NEW JERSEY 07054
US
News
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025
Coffee price forecast: 2025-2030 third-party coffee target
Coffee prices have cooled considerably in the past few months. Is a rebound in store or will they continue to fall?
09:42, 12 March 2025
The Simpsons predicted XRP to hit $589: Has the show got it right again?
Did the animated TV show predict a breakout for the XRP cryptocurrency?
11:00, 11 March 2025
Rolls-Royce share price forecast: third- party price target
Our Rolls-Royce share price forecast looks at the outlook for the FTSE 100-listed engineering company after a tough few years.
14:58, 10 March 2025
Gasoline petrol price forecast 2025-2030: Third-party price target
Discover third-party gasoline (petrol) price predictions for 2025 and beyond, with analyst targets, historical prices, and trading strategies.
10:27, 3 March 2025
USD forecast - third party data round up
The DXY hit a seven-month low in January, just a few months after a multi-decade peak in late September.
10:02, 27 February 2025
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025People also watch
Still looking for a broker you can trust?
Join the 710,000+ traders worldwide that chose to trade with Capital.com